Related Experiment Video
Updated: Jan 6, 2026

10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
11.0K
New Therapeutic Modalities in Prion Diseases.
Alberto Pettinari1, Elisa Uliassi1, Maria Laura Bolognesi2
1Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Sub-Cellular Biochemistry
|September 26, 2025
Summary
Novel prion disease therapies show promise, targeting protein issues and using gene therapy. Advances in diagnostics aid early treatment for these fatal neurodegenerative disorders.
Area of Science:
- Neurodegenerative diseases
- Prion biology
- Therapeutic development
Background:
- Prion diseases are fatal neurodegenerative disorders with no current effective treatments.
- Decades of drug discovery have yielded limited progress in disease-modifying therapies.
- Recent advances offer new therapeutic strategies targeting prion pathology.
Purpose of the Study:
- To explore novel therapeutic modalities for prion diseases.
- To critically assess the advantages and limitations of emerging treatments.
- To highlight the expanding therapeutic options for prion diseases.
Main Methods:
- Focus on small-molecule theranostics.
- Investigate compounds promoting prion protein degradation.
- Examine RNA-based therapeutics and gene therapy approaches.
Main Results:
- Novel modalities target prion protein biogenesis, aggregation, and degradation.
- Advancements in diagnostics enable early and accurate prion disease detection.
- Emerging therapeutics show translational potential.
Conclusions:
- Innovative therapeutic strategies are expanding the options for prion disease treatment.
- Small molecules, RNA therapeutics, and gene therapy offer new hope.
- Early diagnosis is crucial for effective application of novel prion disease therapies.
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Microorganisms in Medicine and Therapeutics
908
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
908

